Pediatrics: Clinical Trials

11 trials for Pediatrics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 recruiting, 1 unknown, 1 withdrawn. 11 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 311Completed 7, Recruiting 2, Unknown 1, Withdrawn 1

Follow Pediatrics: new trials by email Literature Review of Pediatrics trials Research Report on Pediatrics

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Morphine or Ketamine for Analgesia
Ketamine hydrochloride, Morphine sulphate - Abdominal Pain, Isolated Extremity Fracture
Phase 3RecruitingColumbia University10102026-10-172026-10-20
Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children
Voltaren Topical Gel, Ibuprofen Oral Suspension 100 mg/5mL, ORA-Blend Oral Suspension - Musculoskeletal Injury, Pediatrics
Phase 3RecruitingUniversity of Calgary602026-04-022026-04-13
Norepinephrine for Prevention of Intraoperative Hypotension in Infants Undergoing Kasai Portoenterostomy
Norepinephrine Bitartrate, Placebo - Anesthesia, Pediatrics
Phase 3CompletedKasr El Aini Hospital312022-08-282024-07-09
Effect of Palonosetron, Ondansetron and Dexamethasone in the Prevention of Postoperative Nausea and Vomiting
Ondansetron+Dexamethasone, Palonosetron+Dexamethasone, Dexamethasone - Laparoscopic Surgery, Pediatrics
Phase 3UnknownSelcuk University662022-06-012022-06-30
The Hemodynamic Effects of Different Volumes of Bupivacaine 0.25% Caudal Blocks in Pediatrics Undergoing Lower Abdominal Surgeries as Measured by Electrical Cardiometry
Bupivacaine Hydrochloride - Anesthesia, Caudal, Pediatrics
Phase 3CompletedKasr El Aini Hospital1052021-11-152024-07-09
BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
Botulinum Toxin Type A - Pediatrics, Muscle Spasticity
Phase 3CompletedAllergan3702012-11-052019-08-21
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Botulinum Toxin Type A - Pediatrics, Muscle Spasticity
Phase 3CompletedAllergan2202012-10-302019-08-21
BOTOX® Treatment in Pediatric Lower Limb Spasticity
botulinum toxin Type A, Normal Saline (Placebo) - Pediatrics, Muscle Spasticity
Phase 3CompletedAllergan3842012-09-112018-08-14
BOTOX® Treatment in Pediatric Upper Limb Spasticity
botulinum toxin Type A, Normal Saline (Placebo) - Pediatrics, Muscle Spasticity
Phase 3CompletedAllergan2352012-07-122018-08-14
Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children
Dexmedetomidine, Saline - Agitation, Anesthesia
Phase 3CompletedSt. Luke's-Roosevelt Hospital Center332009-08-012018-11-27
An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients
fentanyl iontophoretic transdermal system (40mcg) No placebo, fentanyl iontophoretic transdermal system (40mcg) - Pain, Postoperative, Pediatrics
Phase 3WithdrawnAlza Corporation, DE, USA2008-10-012014-03-03

Narrower conditions

Cerebral Palsy (4)  ·  Muscle Spasticity (4)  ·  Agnosia (2)  ·  Stroke (2)  ·  Abdominal Pain (1)  ·  Anxiety Disorders (1)  ·  Biliary Atresia (1)  ·  Depression (1)  ·  Emergence Delirium (1)  ·  Emergencies (1)  ·  Fractures, Bone (1)  ·  Hypotension (1)  ·  Knee Injuries (1)  ·  Pain (1)  ·  Pain, Postoperative (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (8)  ·  Nervous System Diseases (7)  ·  Neurologic Manifestations (7)  ·  Brain Damage, Chronic (4)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Muscle Hypertonia (4)  ·  Muscular Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Neuromuscular Manifestations (4)  ·  Pathologic Processes (4)  ·  Cardiovascular Diseases (3)  ·  Neurobehavioral Manifestations (3)  ·  Postoperative Complications (3)

Interventions

Botulinum Toxins, Type A (4)  ·  Saline Solution (2)  ·  Bupivacaine (1)  ·  Dexamethasone (1)  ·  Dexmedetomidine (1)  ·  Ketamine (1)  ·  Morphine (1)  ·  Norepinephrine (1)  ·  Sodium Chloride (1)  ·  diclofenac diethylamine (1)

Sponsors

Allergan (4)  ·  Kasr El Aini Hospital (2)  ·  Alza Corporation, DE, USA (1)  ·  Columbia University (1)  ·  Selcuk University (1)  ·  St. Luke's-Roosevelt Hospital Center (1)  ·  University of Calgary (1)

Countries

United States (6)  ·  Turkey (Türkiye) (5)  ·  Hungary (4)  ·  Philippines (4)  ·  Poland (4)  ·  Russia (4)  ·  South Korea (4)  ·  Thailand (4)  ·  Canada (3)  ·  Egypt (2)  ·  Italy (2)

Top investigators

Emily McCusker (2)  ·  Rozalina Dimitrova (2)  ·  Amy L Drendel, DO, MS (1)  ·  Daniel S Tsze, MD, MPH (1)  ·  Jolie Narang, M.D. (1)  ·  Khaled Sarhan, MD (1)  ·  Mohamed M Eltorki, MBChB, MSc (1)

Results publications

PMID 36794826, PMID 40250622

NIH funding

U01HD116253 (1)